AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Ames, RS Lee, D Foley, JJ Jurewicz, AJ Tornetta, MA Bautsch, W Settmacher, B Klos, A Erhard, KF Cousins, RD Sulpizio, AC Hieble, JP McCafferty, G Ward, KW Adams, JL Bondinell, WE Underwood, DC Osborn, RR Badger, AM Sarau, HM
Citation: Rs. Ames et al., Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models, J IMMUNOL, 166(10), 2001, pp. 6341-6348

Authors: Cousins, RD
Citation: Rd. Cousins, Comment on "Improved probability method for estimating signal in the presence of background" - art. no. 098301, PHYS REV D, 6209(9), 2000, pp. 8301

Authors: Astier, P Cardini, A Cousins, RD Letessier-Selvon, A Popov, BA Vinogradova, T
Citation: P. Astier et al., Kalman filter track fits and track breakpoint analysis, NUCL INST A, 450(1), 2000, pp. 138-154

Authors: Miller, WH Alberts, DP Bhatnagar, PK Bondinell, WE Callahan, JF Calvo, RR Cousins, RD Erhard, KF Heerding, DA Keenan, RM Kwon, C Manley, PJ Newlander, KA Ross, ST Samanen, JM Uzinskas, IN Venslavsky, JW Yuan, CCK Haltiwanger, RC Gowen, M Hwang, SM James, IE Lark, MW Rieman, DJ Stroup, GB Azzarano, LM Salyers, KL Smith, BR Ward, KW Johanson, KO Huffman, WF
Citation: Wh. Miller et al., Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic, J MED CHEM, 43(1), 2000, pp. 22-26

Authors: Keenan, RM Miller, WH Barton, LS Bondinell, WE Cousins, RD Eppley, DF Hwang, SM Kwon, C Lago, MA Nguyen, TT Smith, BR Uzinskas, IN Yuan, CCK
Citation: Rm. Keenan et al., Orally bioavailable nonpeptide vitronectin receptor antagonists containing2-aminopyridine arginine mimetics, BIOORG MED, 9(13), 1999, pp. 1801-1806

Authors: Miller, WH Bondinell, WE Cousins, RD Erhard, KF Jakas, DR Keenan, RM Ku, TW Newlander, KA Ross, ST Haltiwanger, RC Bradbeer, J Drake, FH Gowen, M Hoffman, SJ Hwang, SM James, IE Lark, MW Lechowska, B Rieman, DJ Stroup, GB Vasko-Moser, JA Zembryki, DL Azzarano, LM Adams, PC Salyers, KL Smith, BR Ward, KW Johanson, KO Huffman, WF
Citation: Wh. Miller et al., Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model, BIOORG MED, 9(13), 1999, pp. 1807-1812

Authors: Ward, KW Azzarano, LM Bondinell, WE Cousins, RD Huffman, WF Jakas, DR Keenan, RM Ku, TW Lundberg, D Miller, WH Mumaw, JA Newlander, KA Pirhalla, JL Roethke, TJ Salyers, KL Souder, PR Stelman, GJ Smith, BR
Citation: Kw. Ward et al., Preclinical pharmacokinetics and interspecies scaling of a novel vitronectin receptor antagonist, DRUG META D, 27(11), 1999, pp. 1232-1241

Authors: Keenan, RM Miller, WH Lago, MA Ali, FE Bondinell, WE Callahan, JF Calvo, RR Cousins, RD Hwang, SM Jakas, DR Ku, TW Kwon, C Nguyen, TT Reader, VA Rieman, DJ Ross, ST Takata, DT Uzinskas, IN Yuan, CCK Smith, BR
Citation: Rm. Keenan et al., Benzimidazole derivatives as arginine mimetics in 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonists, BIOORG MED, 8(22), 1998, pp. 3165-3170

Authors: Keenan, RM Lago, MA Miller, WH Ali, FE Cousins, RD Hall, LB Hwang, SM Jakas, DR Kwon, C Louden, C Nguyen, TT Ohlstein, EH Rieman, DJ Ross, ST Samanen, JM Smith, BR Stadel, J Takata, DT Vickery, L Yuan, CCK Yue, TL
Citation: Rm. Keenan et al., Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model, BIOORG MED, 8(22), 1998, pp. 3171-3176
Risultati: 1-9 |